Clinical Trials Directory

Trials / Completed

CompletedNCT04754529

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Influence of Yoga on Cancer-Related Stress in Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial develops and test a yoga intervention in improving cancer-related stress in cancer survivors. The online hatha yoga intervention of breathing and movement incorporates both restorative poses, breathing techniques, guided meditation and may reduce stress levels and improve overall quality of health in cancer survivors.

Detailed description

PRIMARY OBJECTIVE: I. To develop and test the feasibility of a standardized 12-week online hatha yoga intervention (n=30) of breathing and movement incorporating both restorative poses, breathing techniques, guided meditation. SECONDARY OBJECTIVES: I. To evaluate the yoga intervention in relation to self-reported levels of stress and quality of life in cancer survivors (n=30). II. Feasibility of collecting blood and saliva at baseline and post-intervention for stress biomarkers, including cortisol and norepinephrine. EXPLORATORY OBJECTIVE: I. To determine how behavior change, quality of life (QoL), and biomarkers of adrenergic stress, inflammation, and immunosuppression are affected by a 12-week online yoga program completed by cancer survivors. OUTLINE: Patients receive online yoga intervention once a week (QW) for 12 weeks. After completion of study, patients are followed up at 3 months.

Conditions

Interventions

TypeNameDescription
OTHERQuality-of-Life AssessmentAncillary studies
OTHERSurvey AdministrationAncillary studies
OTHERYogaReceive yoga intervention

Timeline

Start date
2021-11-11
Primary completion
2024-03-22
Completion
2024-06-18
First posted
2021-02-15
Last updated
2025-06-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04754529. Inclusion in this directory is not an endorsement.